Atlas Trials

A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy Volunteers

Clinical trial NCT04210388 · COMPLETED

Trial details

NCT number
NCT04210388
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Coronary Artery Disease (CAD)
Start date
2020-01-14
Primary completion
2020-03-09
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.